|
Revenue Interest Purchase
Agreement with PDL BioPharma, Inc. (“PDL”) for
aggregate of $20,800,000 with amounts payable monthly at 9.95% of
Net Revenues through September 2014; and the greater of (i) 9.95%
of product revenue or (ii) specific quarterly amounts varying from
approximately $1.3 million to $2.5 million per quarter through
September 2020. The minimum annual payment amounts are as follows:
2014—$1,250,805, 2015—$6,781,440,
2016—$9,232,642, 2017 and 2018—$9,000,000,
2019—$9,063,000 and 2020—$6,939,000.
|
|
$ |
23,383,692 |
|
|
$ |
21,580,252 |
|